Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-29

Clinical Trial Update: Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 3 months vs 6 months of combination chemotherapy in stage III colorectal cancer (colon cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN